Updated Report Package “The Outlook for Pharmaceuticals in North East Asia” Published by MarketPublishers.com19 Sep 2011 • by Natalie Aster
LONDON – China, Japan, South Korea and Taiwan (geographically located in North East Asia) are currently undergoing different phases of development, particularly, in the growth of their respective pharmaceutical markets.
These four countries represent highly developed pharmaceutical markets with advanced healthcare systems and high levels of spending, both in the private and public sectors. However, their respective governments’s measures to temper escalating spending by introducing various cost containment strategies (including periodical changes to reimbursement prices and the encouragement of generic substitution) were effective not to the full. Spending kept on rising due to the ageing population and the high healthcare standards. In all probability, healthcare costs will remain on an upward trend in the long term.
Updated market research report package “The Outlook for Pharmaceuticals in North East Asia” worked out by Espicom Business Intelligence provides critical business insights into the prospects for, and risks in, leading pharmaceutical markets across China, Japan, South Korea and Taiwan. Each report tracks the latest developments with the news service within the respective country, outlines critical issues and drivers which are shaping the pertinent market, evaluates the environment for branded and generic operators and overviews the rapidly growing biologic sector. Moreover, five-year market forecasts are featured as well.
Report Package Details:
Title: The Outlook for Pharmaceuticals in North East Asia
Published: September, 2011
Price: US$ 3,490.00
To order the report package or ask for free sample pages, please contact email@example.com
The Market Publishers, Ltd.
Tel: +44 208 144 6009
Fax: +44 207 900 3970